| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 10, 1350-1357, Copyright © 1996 by Endocrine Society
ARTICLES |
Y Zhao, JE Nichols, R Valdez, CR Mendelson and ER Simpson
Department of Obstetrics/Gynecology, University of Texas Southwestern Medical Center, Dallas 75235, USA.
Expression of aromatase P450 (P450arom; the product of the CYP19 gene) in human adipose stromal cells in primary culture is markedly stimulated by serum in the presence of dexamethasone (DEX). Under these conditions, the majority of P450arom transcripts contain untranslated exon 1.4 at their 5'-ends. Previously, we observed that the region of the CYP19 gene upstream of exon 1.4 contains a TATA-less promoter, a glucocorticoid response element, and an interferon-gamma-activating sequence. These act to mediate the action of interleukin-6 and related cytokines to stimulate aromatase expression in the presence of DEX. In the present study, we found that tumor necrosis factor-alpha (TNF alpha) also acts synergistically with DEX to stimulate aromatase expression in adipose stromal cells in serum-free medium. We observed that the action of TNF alpha can be mimicked by ceramide. Maximal aromatase activity was obtained when cells were incubated with 5 ng/ml TNF alpha or 100 nM ceramide in the presence of 250 nM DEX. Levels of c- fos and c-jun proteins also were increased by TNF alpha or ceramide in the presence of DEX. Upstream of the interferon-gamma-activating sequence site there is an imperfect activating protein-1 (AP-1) binding site (2-bp mismatch). Gel retardation analysis using nucleotide probes containing the putative AP-1-binding sequence and nuclear extracts of human adipose stromal cells cultured in the presence of TNF alpha or ceramide plus DEX revealed that adipose stromal cells nuclear proteins bind to this site and that binding was competed by a 100-fold excess of a consensus AP-1 sequence. In addition, binding activity was competed by both anti-c-fos and anti-c-jun sera. Mutation or deletion of the putative AP-1 element resulted in the loss of TNF alpha- plus DEX- induced activity of reporter constructs comprised of 515 bp of the exon 1.4 flanking sequence linked to the luciferase gene. These results suggest that TNF alpha, probably acting through ceramide formation, stimulates the binding of both c-fos and c-jun to the AP-1 element upstream of exon 1.4. These act cooperatively with the ligand-activated glucocorticoid receptor to induce aromatase expression in adipose stromal cells in primary culture. We conclude that this TNF alpha signal transduction pathway may play an important role in the regulation of estrogen biosynthesis in adipose tissue.
This article has been cited by other articles:
![]() |
C. Adrie, E. Azoulay, A. Francais, C. Clec'h, L. Darques, C. Schwebel, D. Nakache, S. Jamali, D. Goldgran-Toledano, M. Garrouste-Orgeas, et al. Influence of Gender on the Outcome of Severe Sepsis: A Reappraisal Chest, December 1, 2007; 132(6): 1786 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramirez-Lorca, A. Grilo, M. T. Martinez-Larrad, L. Manzano, F. J. Serrano-Hernando, F. J. Moron, V. Perez-Gonzalez, J. L. Gonzalez-Sanchez, J. Fresneda, R. Fernandez-Parrilla, et al. Sex and Body Mass Index Specific Regulation of Blood Pressure by CYP19A1 Gene Variants Hypertension, November 1, 2007; 50(5): 884 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, S. Reierstad, Z. Lin, M. Lu, C. Brooks, N. Li, J. Innes, and S. E. Bulun Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts Cancer Res., September 15, 2007; 67(18): 8914 - 8922. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Vona-Davis and D. P Rose Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression Endocr. Relat. Cancer, June 1, 2007; 14(2): 189 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Gosman, H. I. Katcher, and R. S. Legro Obesity and the role of gut and adipose hormones in female reproduction Hum. Reprod. Update, September 1, 2006; 12(5): 585 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Straub, P. Harle, M. Kriegel, J. Scholmerich, and H.-M. Lorenz Adrenal and Gonadal Hormone Variations during a Febrile Attack in a Woman with Tumor Necrosis Factor Receptor-Associated Periodic Syndrome J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5884 - 5887. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al. Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Diaz-Cruz, C. L. Shapiro, and R. W. Brueggemeier Cyclooxygenase Inhibitors Suppress Aromatase Expression and Activity in Breast Cancer Cells J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2563 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Miyoshi, S. J. Kim, K. Akazawa, S. Kamigaki, S. Ueda, T. Yanagisawa, T. Inoue, T. Taguchi, Y. Tamaki, and S. Noguchi Down-Regulation of Intratumoral Aromatase Messenger RNA Levels by Docetaxel in Human Breast Cancers Clin. Cancer Res., December 15, 2004; 10(24): 8163 - 8169. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kovacic, C. J. Speed, E. R. Simpson, and C. D. Clyne Inhibition of Aromatase Transcription Via Promoter II by Short Heterodimer Partner in Human Preadipocytes Mol. Endocrinol., January 1, 2004; 18(1): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bourguiba, S. Chater, C. Delalande, M. Benahmed, and S. Carreau Regulation of Aromatase Gene Expression in Purified Germ Cells of Adult Male Rats: Effects of Transforming Growth Factor {beta}, Tumor Necrosis Factor {alpha}, and Cyclic Adenosine 3',5'-Monosphosphate Biol Reprod, August 1, 2003; 69(2): 592 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. Feltus, W. J. Kovacs, W. Nicholson, C. M. Silva, S. K. Nagdas, N. A. Ducharme, and M. H. Melner Epidermal Growth Factor Increases Cortisol Production and Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase Expression in Human Adrenocortical Carcinoma Cells: Evidence for a Stat5-Dependent Mechanism Endocrinology, May 1, 2003; 144(5): 1847 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Yang, M. Shozu, K. Murakami, H. Sumitani, T. Segawa, T. Kasai, and M. Inoue Spatially Heterogenous Expression of Aromatase P450 through Promoter II Is Closely Correlated with the Level of Steroidogenic Factor-1 Transcript in Endometrioma Tissues J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3745 - 3753. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Rubin, J. H. Duong, C. D. Clyne, C. J. Speed, Y. Murata, C. Gong, and E. R. Simpson Ligands for the Peroxisomal Proliferator-Activated Receptor {gamma} and the Retinoid X Receptor Inhibit Aromatase Cytochrome P450 (CYP19) Expression Mediated by Promoter II in Human Breast Adipose Endocrinology, August 1, 2002; 143(8): 2863 - 2871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. HERRMANN, J. SCHOLMERICH, and R. H. STRAUB Influence of Cytokines and Growth Factors on Distinct Steroidogenic Enzymes in Vitro: A Short Tabular Data Collection Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 166 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Clyne, C. J. Speed, J. Zhou, and E. R. Simpson Liver Receptor Homologue-1 (LRH-1) Regulates Expression of Aromatase in Preadipocytes J. Biol. Chem., May 31, 2002; 277(23): 20591 - 20597. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Simpson and S. R. Davis Minireview: Aromatase and the Regulation of Estrogen Biosynthesis--Some New Perspectives Endocrinology, November 1, 2001; 142(11): 4589 - 4594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhou, B. Gurates, S. Yang, S. Sebastian, and S. E. Bulun Malignant Breast Epithelial Cells Stimulate Aromatase Expression via Promoter II in Human Adipose Fibroblasts: An Epithelial-Stromal Interaction in Breast Tumors Mediated by CCAAT/Enhancer Binding Protein {beta} Cancer Res., March 1, 2001; 61(5): 2328 - 2334. [Abstract] [Full Text] |
||||
![]() |
Y. Yasui, J. D. Potter, J. L. Stanford, M. A. Rossing, M. D. Winget, M. Bronner, and J. Daling Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection Cancer Epidemiol. Biomarkers Prev., January 1, 2001; 10(1): 9 - 16. [Abstract] [Full Text] |
||||
![]() |
G. L. Rubin, Y. Zhao, A. M. Kalus, and E. R. Simpson Peroxisome Proliferator-activated Receptor {{gamma}} Ligands Inhibit Estrogen Biosynthesis in Human Breast Adipose Tissue: Possible Implications for Breast Cancer Therapy Cancer Res., March 1, 2000; 60(6): 1604 - 1608. [Abstract] [Full Text] |
||||
![]() |
M. Shozu, Y. Zhao, S. E. Bulun, and E. R. Simpson Multiple Splicing Events Involved in Regulation of Human Aromatase Expression by a Novel Promoter, I.6 Endocrinology, April 1, 1998; 139(4): 1610 - 1617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |